COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89bio, Inc. | Common | 282559103 | 2,006,767 | 105,898 | SH | | SOLE | | 2,006,767 | 0 | 0 |
Abbott Laboratories | Common | 002824100 | 60,228,644 | 552,455 | SH | | SOLE | | 60,228,644 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 73,512,595 | 545,629 | SH | | SOLE | | 73,512,595 | 0 | 0 |
Acadia Healthcare Company, Inc. | Common | 00404A109 | 8,036,632 | 100,912 | SH | | SOLE | | 8,036,632 | 0 | 0 |
Adaptive Biotechnologies Corp. | Common | 00650F109 | 2,833,506 | 422,281 | SH | | SOLE | | 2,833,506 | 0 | 0 |
Adicet Bio, Inc. | Common | 007002108 | 97,999 | 40,329 | SH | | SOLE | | 97,999 | 0 | 0 |
Affimed N.V. | Common | N01045108 | 350,568 | 586,038 | SH | | SOLE | | 350,568 | 0 | 0 |
Agilent Technologies, Inc. | Common | 00846U101 | 5,193,718 | 43,191 | SH | | SOLE | | 5,193,718 | 0 | 0 |
Akero Therapeutics, Inc. | Common | 00973Y108 | 2,871,295 | 61,497 | SH | | SOLE | | 2,871,295 | 0 | 0 |
Alkermes plc | Shares | G01767105 | 9,690,887 | 309,613 | SH | | SOLE | | 9,690,887 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 27,202,067 | 143,214 | SH | | SOLE | | 27,202,067 | 0 | 0 |
Altimmune, Inc. | Common | 02155H200 | 264,750 | 75,000 | SH | | SOLE | | 264,750 | 0 | 0 |
ALX Oncology Holdings Inc. | Common | 00166B105 | 497,245 | 66,211 | SH | | SOLE | | 497,245 | 0 | 0 |
Amerisourcebergen Corp. | Common | 03073E105 | 3,928,843 | 20,417 | SH | | SOLE | | 3,928,843 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 136,883,989 | 616,539 | SH | | SOLE | | 136,883,989 | 0 | 0 |
Amylyx Pharmaceuticals, Inc. | Common | 03237H101 | 2,243,431 | 104,007 | SH | | SOLE | | 2,243,431 | 0 | 0 |
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 15,782,893 | 173,248 | SH | | SOLE | | 15,782,893 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y506 | 65,896 | 32,461 | SH | | SOLE | | 65,896 | 0 | 0 |
Arcus Biosciences, Inc. | Common | 03969F109 | 666,960 | 32,839 | SH | | SOLE | | 666,960 | 0 | 0 |
Arcutis Biotherapeutics, Inc. | Common | 03969K108 | 1,418,769 | 148,874 | SH | | SOLE | | 1,418,769 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 1,828,593 | 539,408 | SH | | SOLE | | 1,828,593 | 0 | 0 |
argenx SE | Sponsored ADR | 04016X101 | 25,547,971 | 65,553 | SH | | SOLE | | 25,547,971 | 0 | 0 |
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 12,387,097 | 138,791 | SH | | SOLE | | 12,387,097 | 0 | 0 |
Assertio Holdings, Inc. | Common | 04546C205 | 2,225,317 | 410,575 | SH | | SOLE | | 2,225,317 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 69,900,701 | 976,676 | SH | | SOLE | | 69,900,701 | 0 | 0 |
Avantor, Inc. | Common | 05352A100 | 9,437,884 | 459,488 | SH | | SOLE | | 9,437,884 | 0 | 0 |
Baxter International, Inc. | Common | 071813109 | 14,778,297 | 324,370 | SH | | SOLE | | 14,778,297 | 0 | 0 |
Beam Therapeutics Inc. | Common | 07373V105 | 505,037 | 15,817 | SH | | SOLE | | 505,037 | 0 | 0 |
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 3,735,742 | 20,952 | SH | | SOLE | | 3,735,742 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481404 | 2,220 | 6,000 | SH | | SOLE | | 2,220 | 0 | 0 |
Bicycle Therapeutics PLC | Sponsored ADS | 088786108 | 1,131,506 | 44,338 | SH | | SOLE | | 1,131,506 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | Common | 09058V103 | 3,551,877 | 504,528 | SH | | SOLE | | 3,551,877 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 70,626,564 | 247,943 | SH | | SOLE | | 70,626,564 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 18,271,191 | 210,789 | SH | | SOLE | | 18,271,191 | 0 | 0 |
BioNTech SE | Sponsored ADS | 09075V102 | 11,209,394 | 103,858 | SH | | SOLE | | 11,209,394 | 0 | 0 |
Black Diamond Therapeutics, Inc. | Common | 09203E105 | 666,550 | 131,990 | SH | | SOLE | | 666,550 | 0 | 0 |
Boston Scientific Corp. | Common | 101137107 | 35,579,861 | 657,790 | SH | | SOLE | | 35,579,861 | 0 | 0 |
Bridgebio Pharma, Inc. | Common | 10806X102 | 2,595,841 | 150,921 | SH | | SOLE | | 2,595,841 | 0 | 0 |
Bristol-Myers Squibb Company | Common | 110122108 | 29,320,947 | 458,498 | SH | | SOLE | | 29,320,947 | 0 | 0 |
Caribou Biosciences, Inc. | Common | 142038108 | 2,410,375 | 567,147 | SH | | SOLE | | 2,410,375 | 0 | 0 |
Cerevel Therapeutics Holdings, Inc. | Common | 15678U128 | 5,610,395 | 176,483 | SH | | SOLE | | 5,610,395 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 23,376,226 | 111,183 | SH | | SOLE | | 23,376,226 | 0 | 0 |
Chinook Therapeutics, Inc. | Common | 16961L106 | 5,796,156 | 150,863 | SH | | SOLE | | 5,796,156 | 0 | 0 |
Codexis Inc | Common | 192005106 | 193,550 | 69,125 | SH | | SOLE | | 193,550 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 388,674 | 88,335 | SH | | SOLE | | 388,674 | 0 | 0 |
Community Healthcare Trust Inc. | Common | 20369C106 | 491,998 | 14,900 | SH | | SOLE | | 491,998 | 0 | 0 |
Corbus Pharmaceuticals Holdings, Inc. | Common | 21833P301 | 40,321 | 5,143 | SH | | SOLE | | 40,321 | 0 | 0 |
Crinetics Pharmaceuticals, Inc. | Common | 22663K107 | 1,415,093 | 78,529 | SH | | SOLE | | 1,415,093 | 0 | 0 |
CRISPR Therapeutics AG | Namen AKT | H17182108 | 1,267,136 | 22,571 | SH | | SOLE | | 1,267,136 | 0 | 0 |
CVS Health Corp. | Common | 126650100 | 6,472,020 | 93,621 | SH | | SOLE | | 6,472,020 | 0 | 0 |
Cytokinetics, Inc. | Common | 23282W605 | 7,144,596 | 219,025 | SH | | SOLE | | 7,144,596 | 0 | 0 |
Danaher Corp. | Common | 235851102 | 34,275,120 | 142,813 | SH | | SOLE | | 34,275,120 | 0 | 0 |
Denali Therapeutics, Inc. | Common | 24823R105 | 9,585,704 | 324,829 | SH | | SOLE | | 9,585,704 | 0 | 0 |
Dexcom, Inc. | Common | 252131107 | 29,396,277 | 228,747 | SH | | SOLE | | 29,396,277 | 0 | 0 |
Diversified Healthcare Trust | Common | 25525P107 | 804,870 | 357,720 | SH | | SOLE | | 804,870 | 0 | 0 |
Edgewise Therapeutics, Inc. | Common | 28036F105 | 1,165,740 | 150,418 | SH | | SOLE | | 1,165,740 | 0 | 0 |
Edwards Lifesciences Corp. | Common | 28176E108 | 17,884,685 | 189,597 | SH | | SOLE | | 17,884,685 | 0 | 0 |
Elevance Health, Inc. | Common | 036752103 | 50,680,160 | 114,070 | SH | | SOLE | | 50,680,160 | 0 | 0 |
Eli Lilly and Company | Common | 532457108 | 100,057,821 | 213,352 | SH | | SOLE | | 100,057,821 | 0 | 0 |
Exelixis, Inc. | Common | 30161Q104 | 13,886,071 | 726,639 | SH | | SOLE | | 13,886,071 | 0 | 0 |
Fulcrum Therapeutics, Inc. | Common | 359616109 | 847,730 | 256,888 | SH | | SOLE | | 847,730 | 0 | 0 |
Fusion Pharmaceuticals Inc. | Common | 36118A100 | 203,084 | 43,394 | SH | | SOLE | | 203,084 | 0 | 0 |
G1 Therapeutics, Inc. | Common | 3621LQ109 | 1,055,434 | 423,869 | SH | | SOLE | | 1,055,434 | 0 | 0 |
Galera Therapeutics, Inc. | Common | 36338D108 | 2,802,927 | 898,374 | SH | | SOLE | | 2,802,927 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 118,216,440 | 1,533,884 | SH | | SOLE | | 118,216,440 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 1,596,810 | 174,897 | SH | | SOLE | | 1,596,810 | 0 | 0 |
GSK plc | Sponsored ADR | 37733W204 | 1,491,605 | 41,852 | SH | | SOLE | | 1,491,605 | 0 | 0 |
Guardant Health, Inc. | Common | 40131M109 | 12,389,807 | 346,084 | SH | | SOLE | | 12,389,807 | 0 | 0 |
Harpoon Therapeutics, Inc. | Common | 41358P106 | 184,536 | 259,910 | SH | | SOLE | | 184,536 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 25,007,662 | 82,403 | SH | | SOLE | | 25,007,662 | 0 | 0 |
Healthcare Realty Trust Inc. | Common | 42226K105 | 3,294,578 | 174,686 | SH | | SOLE | | 3,294,578 | 0 | 0 |
Healthpeak Properties, Inc. | Common | 42250P103 | 3,022,879 | 150,392 | SH | | SOLE | | 3,022,879 | 0 | 0 |
HilleVax, Inc. | Common | 43157M102 | 464,130 | 27,000 | SH | | SOLE | | 464,130 | 0 | 0 |
Horizon Therapeutics plc | Common | G46188101 | 7,448,911 | 72,425 | SH | | SOLE | | 7,448,911 | 0 | 0 |
Humana Inc. | Common | 444859102 | 16,451,701 | 36,794 | SH | | SOLE | | 16,451,701 | 0 | 0 |
I-Mab | Sponsored ADS | 44975P103 | 486,114 | 162,580 | SH | | SOLE | | 486,114 | 0 | 0 |
Icon plc | Shares | G4705A100 | 2,335,367 | 9,334 | SH | | SOLE | | 2,335,367 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 29,428,167 | 58,595 | SH | | SOLE | | 29,428,167 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 63,180,193 | 336,979 | SH | | SOLE | | 63,180,193 | 0 | 0 |
Immunovant, Inc. | Common | 45258J102 | 6,377,714 | 336,200 | SH | | SOLE | | 6,377,714 | 0 | 0 |
Inspire Medical Systems, Inc. | Common | 457730109 | 7,147,924 | 22,018 | SH | | SOLE | | 7,147,924 | 0 | 0 |
Insulet Corp. | Common | 45784P101 | 12,642,844 | 43,847 | SH | | SOLE | | 12,642,844 | 0 | 0 |
Intellia Therapeutics, Inc. | Common | 45826J105 | 6,291,090 | 154,269 | SH | | SOLE | | 6,291,090 | 0 | 0 |
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 575,861 | 52,067 | SH | | SOLE | | 575,861 | 0 | 0 |
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 8,322,464 | 131,435 | SH | | SOLE | | 8,322,464 | 0 | 0 |
Intuitive Surgical, Inc. | Common | 46120E602 | 28,716,121 | 83,980 | SH | | SOLE | | 28,716,121 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 3,604,075 | 87,840 | SH | | SOLE | | 3,604,075 | 0 | 0 |
IQVIA Holdings Inc. | Common | 46266C105 | 24,528,925 | 109,129 | SH | | SOLE | | 24,528,925 | 0 | 0 |
Ishares Biothechnology ETF | Common | 464287556 | 3,119,280 | 24,569 | SH | | SOLE | | 3,119,280 | 0 | 0 |
iTeos Therapeutics, Inc. | Common | 46565G104 | 605,531 | 45,735 | SH | | SOLE | | 605,531 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 18,320,163 | 147,779 | SH | | SOLE | | 18,320,163 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 119,468,860 | 721,779 | SH | | SOLE | | 119,468,860 | 0 | 0 |
Karuna Therapeutics, Inc. | Common | 48576A100 | 12,702,422 | 58,577 | SH | | SOLE | | 12,702,422 | 0 | 0 |
Koninklijke Philips N.V. | NY Reg Shares | 500472303 | 2,489,253 | 114,765 | SH | | SOLE | | 2,489,253 | 0 | 0 |
LivaNova plc | Common | G5509L101 | 5,579,126 | 108,480 | SH | | SOLE | | 5,579,126 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 6,019,315 | 182,293 | SH | | SOLE | | 6,019,315 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | Common | 558868105 | 7,954,254 | 34,434 | SH | | SOLE | | 7,954,254 | 0 | 0 |
Mallinckrodt plc | Shares | G5890A102 | 41,357 | 35,048 | SH | | SOLE | | 41,357 | 0 | 0 |
Marinus Pharmaceuticals, Inc. | Common | 56854Q200 | 4,464,557 | 411,101 | SH | | SOLE | | 4,464,557 | 0 | 0 |
McKesson Corp. | Common | 58155Q103 | 26,473,991 | 61,955 | SH | | SOLE | | 26,473,991 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 3,812,740 | 411,743 | SH | | SOLE | | 3,812,740 | 0 | 0 |
Medpace Holdings, Inc. | Common | 58506Q109 | 6,464,896 | 26,918 | SH | | SOLE | | 6,464,896 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 30,343,138 | 344,417 | SH | | SOLE | | 30,343,138 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 84,021,690 | 728,154 | SH | | SOLE | | 84,021,690 | 0 | 0 |
Mereo BioPharma Group plc | ADS | 589492107 | 2,047,428 | 1,551,082 | SH | | SOLE | | 2,047,428 | 0 | 0 |
Mirati Therapeutics, Inc. | Common | 60468T105 | 2,366,154 | 65,490 | SH | | SOLE | | 2,366,154 | 0 | 0 |
Moderna, Inc. | Common | 60770K107 | 41,758,943 | 343,695 | SH | | SOLE | | 41,758,943 | 0 | 0 |
Molina Healthcare, Inc. | Common | 60855R100 | 18,633,501 | 61,856 | SH | | SOLE | | 18,633,501 | 0 | 0 |
MorphoSys AG | Sponsored ADS | 617760202 | 1,323,617 | 177,191 | SH | | SOLE | | 1,323,617 | 0 | 0 |
Natera, Inc. | Common | 632307104 | 1,198,788 | 24,636 | SH | | SOLE | | 1,198,788 | 0 | 0 |
National Health Investors, Inc. | Common | 63633D104 | 526,192 | 10,038 | SH | | SOLE | | 526,192 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 10,647,224 | 112,908 | SH | | SOLE | | 10,647,224 | 0 | 0 |
NexGel, Inc. | Common | 65344E107 | 10,650 | 4,243 | SH | | SOLE | | 10,650 | 0 | 0 |
Nkarta, Inc. | Common | 65487U108 | 63,484 | 28,988 | SH | | SOLE | | 63,484 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 13,746,465 | 136,225 | SH | | SOLE | | 13,746,465 | 0 | 0 |
Novavax, Inc. | Common | 670002401 | 474,034 | 63,800 | SH | | SOLE | | 474,034 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 19,869,002 | 122,777 | SH | | SOLE | | 19,869,002 | 0 | 0 |
Oculis Holding AG | Common | 952KVL905 | 18,823,020 | 1,690,741 | SH | | SOLE | | 18,823,020 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 9,404,429 | 306,433 | SH | | SOLE | | 9,404,429 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 1,739,055 | 51,224 | SH | | SOLE | | 1,739,055 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 59,585,780 | 1,624,476 | SH | | SOLE | | 59,585,780 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 12,222,433 | 873,655 | SH | | SOLE | | 12,222,433 | 0 | 0 |
Praxis Precision Medicines, Inc. | Common | 74006W108 | 86,250 | 75,000 | SH | | SOLE | | 86,250 | 0 | 0 |
Precision BioSciences, Inc. | Common | 74019P108 | 118,105 | 224,534 | SH | | SOLE | | 118,105 | 0 | 0 |
Pyxis Oncology, Inc. | Common | 747324101 | 1,813,256 | 708,303 | SH | | SOLE | | 1,813,256 | 0 | 0 |
R1 RCM Inc. | Common | 77634L105 | 6,583,901 | 356,851 | SH | | SOLE | | 6,583,901 | 0 | 0 |
Rallybio Corporation | Common | 75120L100 | 9,775,199 | 1,727,067 | SH | | SOLE | | 9,775,199 | 0 | 0 |
Reata Pharmaceuticals, Inc. Class A | Class A | 75615P103 | 3,492,130 | 34,250 | SH | | SOLE | | 3,492,130 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 115,985,290 | 161,418 | SH | | SOLE | | 115,985,290 | 0 | 0 |
Repare Therapeutics Inc. | Common | 760273102 | 308,407 | 29,150 | SH | | SOLE | | 308,407 | 0 | 0 |
ResMed Inc. | Common | 761152107 | 7,582,824 | 34,704 | SH | | SOLE | | 7,582,824 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 6,010,468 | 510,660 | SH | | SOLE | | 6,010,468 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 6,654,171 | 123,454 | SH | | SOLE | | 6,654,171 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 20,549,125 | 179,437 | SH | | SOLE | | 20,549,125 | 0 | 0 |
Scholar Rock Holding Corp. | Common | 80706P103 | 820,601 | 108,833 | SH | | SOLE | | 820,601 | 0 | 0 |
Seagen Inc. | Common | 81181C104 | 21,619,224 | 112,331 | SH | | SOLE | | 21,619,224 | 0 | 0 |
Smith & Nephew plc | Sponsored ADR | 83175M205 | 5,860,148 | 181,710 | SH | | SOLE | | 5,860,148 | 0 | 0 |
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 12,286,726 | 147,677 | SH | | SOLE | | 12,286,726 | 0 | 0 |
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 110,083 | 114,670 | SH | | SOLE | | 110,083 | 0 | 0 |
STERIS plc | Shares | G8473T100 | 6,990,579 | 31,072 | SH | | SOLE | | 6,990,579 | 0 | 0 |
Stryker Corp. | Common | 863667101 | 24,751,342 | 81,128 | SH | | SOLE | | 24,751,342 | 0 | 0 |
Sutro Biopharma, Inc. | Common | 869367102 | 457,346 | 98,354 | SH | | SOLE | | 457,346 | 0 | 0 |
Tactile Systems Technology, Inc. | Common | 87357P100 | 1,457,707 | 58,472 | SH | | SOLE | | 1,457,707 | 0 | 0 |
Takeda Pharmaceutical Company Ltd. | Sponsored ADS | 874060205 | 1,650,697 | 105,073 | SH | | SOLE | | 1,650,697 | 0 | 0 |
Tenet Healthcare Corp. | Common | 88033G407 | 12,131,317 | 149,070 | SH | | SOLE | | 12,131,317 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 3,461,172 | 459,651 | SH | | SOLE | | 3,461,172 | 0 | 0 |
The Cigna Group | Common | 125523100 | 27,032,723 | 96,339 | SH | | SOLE | | 27,032,723 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 51,646,467 | 98,987 | SH | | SOLE | | 51,646,467 | 0 | 0 |
Theseus Pharmaceuticals, Inc. | Common | 88369M101 | 699,750 | 75,000 | SH | | SOLE | | 699,750 | 0 | 0 |
TScan Therapeutics, Inc. | Common | 89854M101 | 500,000 | 200,000 | SH | | SOLE | | 500,000 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 4,082,969 | 356,280 | SH | | SOLE | | 4,082,969 | 0 | 0 |
United Therapeutics Corp. | Common | 91307C102 | 9,153,399 | 41,465 | SH | | SOLE | | 9,153,399 | 0 | 0 |
Unitedhealth Group Inc. | Common | 91324P102 | 99,473,735 | 206,961 | SH | | SOLE | | 99,473,735 | 0 | 0 |
Universal Health Realty Income Trust | Common | 91359E105 | 535,656 | 11,258 | SH | | SOLE | | 535,656 | 0 | 0 |
Vaxcyte, Inc. | Common | 92243G108 | 9,699,946 | 194,232 | SH | | SOLE | | 9,699,946 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 3,152,011 | 66,681 | SH | | SOLE | | 3,152,011 | 0 | 0 |
Veradigm, Inc. | Common | 01988P108 | 5,400,108 | 428,580 | SH | | SOLE | | 5,400,108 | 0 | 0 |
Vertex Pharmaceuticals Inc. | Common | 92532F100 | 111,922,512 | 318,043 | SH | | SOLE | | 111,922,512 | 0 | 0 |
VYNE Therapeutics, Inc. | Common | 92941V308 | 30,531 | 7,520 | SH | | SOLE | | 30,531 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 3,355,641 | 41,484 | SH | | SOLE | | 3,355,641 | 0 | 0 |
West Pharmaceutical Services, Inc. | Common | 955306105 | 5,750,819 | 15,036 | SH | | SOLE | | 5,750,819 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 1,415,175 | 56,675 | SH | | SOLE | | 1,415,175 | 0 | 0 |
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 2,598,981 | 67,506 | SH | | SOLE | | 2,598,981 | 0 | 0 |
Zentalis Pharmaceuticals, Inc. | Common | 98943L107 | 1,132,801 | 40,156 | SH | | SOLE | | 1,132,801 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 9,807,034 | 67,356 | SH | | SOLE | | 9,807,034 | 0 | 0 |
Zoetis Inc. | Class A | 98978V103 | 23,577,960 | 136,914 | SH | | SOLE | | 23,577,960 | 0 | 0 |